# The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

> **NCT01455441** · PHASE4 · COMPLETED · sponsor: **Tina Vilsboll** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** Training and liraglutide
- **OTHER:** Training and placebo

## Key facts

- **NCT ID:** NCT01455441
- **Lead sponsor:** Tina Vilsboll
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-06
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01455441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01455441, "The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01455441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*